Cholinergic Deep Brain Stimulation for Alzheimer's Disease

NANot yet recruitingINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

October 31, 2028

Study Completion Date

October 31, 2028

Conditions
Alzheimer Disease, Early OnsetDementiaAlzheimer Disease
Interventions
PROCEDURE

Device Implantation- Boston Scientific, VERCISE GENUS™ system

Participants will be implanted with DBS leads bilaterally, targeting the Nucleus Basalis of Meynert. The study team will record Local Field Potentials with and without stimulation, intraoperatively. These results will help the team determine at the end of the study whether LFP desynchronization (decrease in 5-15 Hz power), or other physiological signature, can be used to predict the location that provides the most effective intervention. Finally, the team will also ascertain the safety of the procedure and NB stimulation itself.

DEVICE

DBS Stimulation - Boston Scientific, VERCISE GENUS™ system

Daily intermittent stimulation (60 Hz x 20s/min)

Trial Locations (1)

37232

Vanderbilt Medical Center, Nashville

Sponsors
All Listed Sponsors
collaborator

Boston Scientific Corporation

INDUSTRY

lead

Vanderbilt University Medical Center

OTHER